Excellent Response With Alpelisib and Bicalutamide for Advanced Salivary Duct Carcinoma With PIK3CA Mutation and High Androgen Receptor Expression—A Case Report

Authors :: Vishal Peshattiwar
Ramya Pragya
Nevitha Athikari
Hardik Sheth
Prashant Kumar
Aditya Shreenivas
Chetan Madre
Sewanti Limaye
Rajan Datar
Hemant Khandare
Janani Sambath
Source :: JCO Precision Oncology
Publication Year :: 2021
Publisher :: Wolters Kluwer Health, 2021.

Subjects :: Cancer Research
Bicalutamide
business.industry
Pik3ca mutation
Case Reports
medicine.disease
Salivary duct carcinoma
Androgen receptor
Text mining
Oncology
medicine
Cancer research
business
medicine.drug

Tools